Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 19/20 | 0.69 |
| ▸ | ADORA1 | P30542 | 11/20 | 0.67 |
| ▸ | ADORA2A | P29274 | 9/20 | 0.67 |
| ▸ | ADORA2B | P29275 | 7/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22750642 | 0.97 | ADORA3 (0.70) | ADORA3ADORA1ADORA2AADORA2B | |
| SCHEMBL22757514 | 0.97 | ADORA3 (0.70) | ADORA3ADORA1ADORA2AADORA2B | |
| SCHEMBL22750648 | 0.86 | ADORA3 (0.69) | ADORA3ADORA1ADORA2AADORA2B | |
| SCHEMBL22750534 | 0.86 | ADORA3 (0.57) | ADORA3ADORA1ADORA2AADORA2B | |
| SCHEMBL22757513 | 0.86 | ADORA3 (0.54) | ADORA3ADORA1ADORA2AADORA2B | |
| SCHEMBL22757494 | 0.85 | ADORA3 (0.58) | ADORA3ADORA1ADORA2AADORA2B | |
| SCHEMBL22750530 | 0.85 | ADORA3 (0.58) | ADORA3ADORA1ADORA2AADORA2B | |
| SCHEMBL22750602 | 0.84 | ADORA3 (0.55) | ADORA3ADORA1ADORA2AADORA2B | |
| SCHEMBL22750502 | 0.82 | ADORA3 (0.64) | ADORA3ADORA1ADORA2AADORA2B | |
| SCHEMBL22750477 | 0.80 | ADORA3 (0.68) | ADORA3ADORA1ADORA2AADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020247546-A1 | ADENOSINE ANALOGS FOR THE TREATMENT OF DISEASE | BIOINTERVENE, INC. (US) | 2020-12-10 | — | — | WO | disclosed |
| WO-2020247546-A1 | ADENOSINE ANALOGS FOR THE TREATMENT OF DISEASE | BIOINTERVENE, INC. (US) | 2020-12-10 | — | — | WO | disclosed |